Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Annales De Biologie Clinique|January 1, 1994
[Comparative study of lipids, apoproteins and lipoproteins in patients with coronary disease and in a control population]C Marzullo, O Michotey, D Bourderont, et al.Anti-Cancer Drugs|March 24, 1998
A phase I/II trial of paclitaxel for non-Hodgkin's lymphoma followed by paclitaxel plus quinine in drug-resistant diseaseT P Miller, E M Chase, R Dorr, et al.Nutrition and Cancer|January 1, 1996
Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green teaH L Gensler, B N Timmermann, S Valcic, et al.Postgraduate Medical Journal|January 1, 1983
Transluminal coronary angioplasty immediately after intracoronary streptolysis in acute myocardial infarctionR Erbel, J Meyer, W Merx, et al.Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|December 1, 1977
Nabilone: a potent antiemetic cannabinol with minimal euphoriaT S Herman, S E Jones, J Dean, et al.Cancer Chemotherapy and Pharmacology|December 29, 2000
A phase I trial of AUC-directed carboplatin with infusional doxorubicin and ifosfamide plus G-CSF in patients with advanced gynecologic malignanciesA M Lopez, M Ketchum, H Nichols, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemiaA F List, C Spier, J Greer, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2001
Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon EH H Chow, Y Cai, D S Alberts, et al.Cancer Chemotherapy and Pharmacology|January 1, 1997
Inhibition of intracellular Ca2+ signalling, cytotoxicity and antitumor activity of the herbicide oryzalin and its analoguesG Powis, A Gallegos, R T Abraham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemiaR Dorr, C Karanes, C Spier, et al.Pageof 5